Patent · US Active

Methods of treating pancreatic cancer

US9855220B2 · kind B2 · utility

18Cited by
49References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 6, 2016
Grant dateJan 2, 2018
Priority date
Expiry dateOct 6, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for the treatment of metastatic pancreatic cancer comprising administration of a composition comprising nanoparticles comprising a taxane (such as paclitaxel) and a carrier protein in combination with gemcitabine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.